Skip to main navigation
eledon logo
  • Overview
    • Focus
    • Patient Stories
    • BESTOW Clinical Trial
    • In the News
  • Science
    • Mechanism of Action
    • Pipeline
  • Team
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Publications & Presentations
    • Corporate Governance
      • Governance Overview
      • Committee Composition
      • Ethics Hotline
    • Financials
      • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Culture/Careers
    • Culture
    • Careers
  • Contact

Event Details

  • Overview
  • News & Events
    • Press Releases
    • Events
    • Publications & Presentations
  • Corporate Governance
    • Governance Overview
    • Committee Composition
    • Ethics Hotline
  • Financials
    • SEC Filings
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Q3-2022 Earnings

11/14/22 at 4:30 PM EST

Click here for the webcast
eledon logo
  • Overview
  • Science
  • Team
  • Investors
  • Culture/Careers
  • Contact
Copyright © 2023 Eledon Pharmaceuticals, Inc. | All Rights Reserved | Privacy Policy | Terms of Use
eledon logo
  • Overview
    • Focus
    • Patient Stories
    • BESTOW Clinical Trial
    • In the News
  • Science
    • Mechanism of Action
    • Pipeline
  • Team
    • Leadership
    • Board of Directors
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events
      • Publications & Presentations
    • Corporate Governance
      • Governance Overview
      • Committee Composition
      • Ethics Hotline
    • Financials
      • SEC Filings
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Resources
      • Investor FAQs
      • Email Alerts
      • Contact IR
  • Culture/Careers
    • Culture
    • Careers
  • Contact